Overview
To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions
Description
To collect prospective observational data on patients undergoing ESD, EFTR or STER for UGI neoplastic lesions
- Lesion characteristics including histology
- Procedural outcomes
- Safety Outcomes
- Efficacy outcomes
Eligibility
Inclusion Criteria:
- UGI neoplastic lesions > 10mm
- Lesions for ESD limited to the mucosal and/or submucosal layer OR
- Lesions for EFTR limited to the muscularis propria layer OR
- Lesions for STER limited to the submucosal and/or muscularis propria layer
- Aged 18 years or older
Exclusion Criteria:
- Age less than 18
- Unable to give informed consent
- Pregnant or lactating patients
- Patients with bleeding diathesis or who cannot discontinue ADP blockers (e.g. clopidogrel, prasugrel) or antithrombotics (e.g. warfarin, dabigatran) periprocedurally